These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9533947)

  • 1. Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease.
    Fontenot AP; Kotzin BL; Comment CE; Newman LS
    Am J Respir Cell Mol Biol; 1998 Apr; 18(4):581-9. PubMed ID: 9533947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung.
    Fontenot AP; Maier LA; Canavera SJ; Hendry-Hofer TB; Boguniewicz M; Barker EA; Newman LS; Kotzin BL
    J Immunol; 2002 Apr; 168(7):3627-34. PubMed ID: 11907128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP.
    Sawyer RT; Parsons CE; Fontenot AP; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Jul; 31(1):122-30. PubMed ID: 14975942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-presentation of beryllium by BAL CD4+ T cells: T cell-T cell interactions and their potential role in chronic beryllium disease.
    Fontenot AP; Edwards DM; Chou YK; Mack DG; LaTocha D; Vandenbark AA; Burrows GG
    Eur J Immunol; 2006 Apr; 36(4):930-9. PubMed ID: 16552706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease.
    Fontenot AP; Canavera SJ; Gharavi L; Newman LS; Kotzin BL
    J Clin Invest; 2002 Nov; 110(10):1473-82. PubMed ID: 12438445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects.
    Mack DG; Lanham AM; Falta MT; Palmer BE; Maier LA; Fontenot AP
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1241-9. PubMed ID: 20299529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of pathogenic T cells in patients with beryllium-induced lung disease.
    Fontenot AP; Falta MT; Freed BM; Newman LS; Kotzin BL
    J Immunol; 1999 Jul; 163(2):1019-26. PubMed ID: 10395700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease.
    Greaves SA; Atif SM; Fontenot AP
    Front Immunol; 2020; 11():474. PubMed ID: 32256501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease.
    Palmer BE; Mack DG; Martin AK; Maier LA; Fontenot AP
    J Allergy Clin Immunol; 2007 Jul; 120(1):184-91. PubMed ID: 17416406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.
    Fontenot AP; Palmer BE; Sullivan AK; Joslin FG; Wilson CC; Maier LA; Newman LS; Kotzin BL
    J Clin Invest; 2005 Oct; 115(10):2886-93. PubMed ID: 16151531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium induces IL-2 and IFN-gamma in berylliosis.
    Tinkle SS; Kittle LA; Schumacher BA; Newman LS
    J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple public TCR repertoires in chronic beryllium disease.
    Bowerman NA; Falta MT; Mack DG; Wehrmann F; Crawford F; Mroz MM; Maier LA; Kappler JW; Fontenot AP
    J Immunol; 2014 May; 192(10):4571-80. PubMed ID: 24719461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease.
    Sawyer RT; Day BJ; Fadok VA; Chiarappa-Zucca M; Maier LA; Fontenot AP; Silveira L; Newman LS
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):470-7. PubMed ID: 15256386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation.
    Chain JL; Martin AK; Mack DG; Maier LA; Palmer BE; Fontenot AP
    J Immunol; 2013 Aug; 191(4):1648-56. PubMed ID: 23851684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis.
    Maier LA; Sawyer RT; Tinkle SS; Kittle LA; Barker EA; Balkissoon R; Rose C; Newman LS
    Eur Respir J; 2001 Mar; 17(3):403-15. PubMed ID: 11405518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly activated T-cell receptor AV2S3(+) CD4(+) lung T-cell expansions in pulmonary sarcoidosis.
    Katchar K; Wahlström J; Eklund A; Grunewald J
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1540-5. PubMed ID: 11401870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.
    Saltini C; Winestock K; Kirby M; Pinkston P; Crystal RG
    N Engl J Med; 1989 Apr; 320(17):1103-9. PubMed ID: 2469014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease.
    Sawyer RT; Fontenot AP; Barnes TA; Parsons CE; Tooker BC; Maier LA; Gillespie MM; Gottschall EB; Silveira L; Hagman J; Newman LS
    Am J Respir Cell Mol Biol; 2007 Feb; 36(2):191-200. PubMed ID: 16980557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TCR usage and cytokine expression in peripheral blood and BAL T cells.
    Bakakos P; Pickard C; Smith JL; Frew AJ
    Clin Exp Immunol; 2002 May; 128(2):295-301. PubMed ID: 11985520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial IL-10 inhibition of the cell-mediated immune response in chronic beryllium disease.
    Tinkle SS; Kittle LA; Newman LS
    J Immunol; 1999 Sep; 163(5):2747-53. PubMed ID: 10453017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.